Browsing Tag
point-of-care diagnostics
4 posts
Lumos Diagnostics (ASX: LDX) wins full U.S. Medicare reimbursement for FebriDx
Lumos Diagnostics secures full Medicare MAC reimbursement for FebriDx, opening doors to U.S. healthcare adoption. Find out what’s next for LDX shares.
Molbio Diagnostics files for Rs 200cr IPO to fund R&D expansion, tech scale-up
Molbio Diagnostics files DRHP to raise ₹200 crore via IPO, aiming to expand Truenat manufacturing and R&D. Discover what’s driving investor interest.
Lumos Diagnostics (ASX: LDX) reaches 500-patient milestone in FebriDx CLIA study
Lumos Diagnostics hits a key 500-patient milestone in its FebriDx CLIA waiver study, triggering BARDA funds. FDA application expected by October 2025.
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa…